Clinical trial
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using…
NCT00220922 · Teva Neuroscience, Inc., Industry · Completed
Key facts
| NCT number | NCT00220922 |
|---|---|
| Title | A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®. |
| Official title | An Open-Label, Randomized, Single Cross-Over Study of Isopropyl Alcohol Wipes Versus No Injection Site Preparation on Local Injection Site Reactions Among Persons With Multiple Sclerosis Who Perform Daily Injections of Copaxone® |
| Lead sponsor | Teva Neuroscience, Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Procedure |
| Interventions | Alcohol Wipes vs. No Alcohol Wipes |
| Enrollment | 50 |
| Start date | Aug 1, 2004 |
| Primary completion | Oct 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 8, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: